Granules India Limited — Board Meeting, 13-11-2025: Outcome of Board Meeting
13-11-2025 | 01:32 pm
13-11-2025 | 01:32 pm
Granules India's Board approved Q2 & H1 FY26 consolidated results. Revenue hit ₹1,297 Cr (Q2) / ₹2,507 Cr (H1), with profit at ₹131 Cr (Q2) / ₹243 Cr (H1). The Gagillapur facility's USFDA warning impacted operations, while Senn Chemicals acquisition was completed.
No comments yet. Be the first to comment!
